@article{ref1,
title="Lipid-lowering medication and risk of injury",
journal="Journal of clinical epidemiology",
year="1999",
author="Bovbjerg, Viktor E. and Siscovick, D. S. and Psaty, B. M. and McCann, B. S. and Koepsell, T. D. and Raghunathan, T. E. and Wagner, E. H.",
volume="52",
number="12",
pages="1197-1200",
abstract="Meta-analyses of early primary prevention trials of lipid-lowering therapies suggested increased risk of injury deaths among treated persons. Our population-based case-control study examined the association of lipid-lowering medication use with fatal and nonfatal injuries in 298 cases and 332 controls. No increased injury risk was observed among current (OR = 0.46, 95% CI 0.18-1.21) or past users (OR = .92, 95% CI 0.44-1.95), after adjustment for behavioral disorders, medical conditions, and health status. Stratified analyses did not reveal sub-groups at significantly increased risk. These results, consistent with recent clinical trials and meta-analyses, suggest no increased injury risk associated with lipid-lowering medications.<p /><p>Language: en</p>",
language="en",
issn="0895-4356",
doi="",
url="http://dx.doi.org/"
}